AnterogenCoLtd Financial Statements From 2010 to 2024
| 065660 Stock | KRW 15,200 30.00 0.20% |
Check AnterogenCoLtd financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AnterogenCoLtd's main balance sheet or income statement drivers, such as , as well as many indicators such as . AnterogenCoLtd financial statements analysis is a perfect complement when working with AnterogenCoLtd Valuation or Volatility modules.
AnterogenCoLtd |
AnterogenCoLtd Company Current Valuation Analysis
AnterogenCoLtd's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current AnterogenCoLtd Current Valuation | 836.51 B |
Most of AnterogenCoLtd's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AnterogenCoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, AnterogenCoLtd has a Current Valuation of 836.51 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The current valuation for all Republic of Korea stocks is significantly lower than that of the firm.
AnterogenCoLtd Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AnterogenCoLtd's current stock value. Our valuation model uses many indicators to compare AnterogenCoLtd value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AnterogenCoLtd competition to find correlations between indicators driving AnterogenCoLtd's intrinsic value. More Info.AnterogenCoLtd is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AnterogenCoLtd by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AnterogenCoLtd's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About AnterogenCoLtd Financial Statements
AnterogenCoLtd stakeholders use historical fundamental indicators, such as AnterogenCoLtd's revenue or net income, to determine how well the company is positioned to perform in the future. Although AnterogenCoLtd investors may analyze each financial statement separately, they are all interrelated. For example, changes in AnterogenCoLtd's assets and liabilities are reflected in the revenues and expenses on AnterogenCoLtd's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in AnterogenCoLtd. Please read more on our technical analysis and fundamental analysis pages.
,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea. ANTEROGEN is traded on Korean Securities Dealers Automated Quotations in South Korea.
Pair Trading with AnterogenCoLtd
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AnterogenCoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnterogenCoLtd will appreciate offsetting losses from the drop in the long position's value.Moving against AnterogenCoLtd Stock
| 0.55 | 030350 | Dragonfly GF Split | PairCorr |
| 0.47 | 336570 | Daishin Balance No8 | PairCorr |
| 0.37 | 047920 | HLB Pharmaceutical | PairCorr |
The ability to find closely correlated positions to AnterogenCoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AnterogenCoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AnterogenCoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AnterogenCoLtd to buy it.
The correlation of AnterogenCoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AnterogenCoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AnterogenCoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AnterogenCoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in AnterogenCoLtd Stock
AnterogenCoLtd financial ratios help investors to determine whether AnterogenCoLtd Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AnterogenCoLtd with respect to the benefits of owning AnterogenCoLtd security.